Cases & Deals

Nanobiotix completes €14.2 million (US$18.4 million) IPO

Clients Nanobiotix

Jones Day advised Nanobiotix, along with underwriters CM-CIC Securities, Gilbert Dupont, and BIL Finance, in connection with the €14.2 million (US$18.4 million) initial public offering and listing on the regulated market of NYSE Euronext in Paris, of Nanobiotix, a pioneer and leader in nanomedicine that has developed a revolutionary concept dedicated to the local treatment of cancer.